ArticleNature communications2018

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.

Olga Kondrashova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.